Using the PREVENT Equations to Guide Aspirin Use for Primary Prevention of Cardiovascular Disease
This cross-sectional study examines eligibility for aspirin for the primary prevention of cardiovascular disease based on the pooled cohort equations and the Predicting Risk of Cardiovascular Disease EVENTs equations.
Authors
- Ahmed Sayed (ORCID: https://orcid.org/0000-0003-0150-8917)
- Salim S. Virani (ORCID: https://orcid.org/0000-0001-9541-6954)
- Amit V. Khera (ORCID: https://orcid.org/0000-0001-6535-5839)
- Ann Marie Návar (ORCID: https://orcid.org/0000-0002-6197-9860)
- Eric David Peterson (ORCID: https://orcid.org/0000-0002-5415-4721)
Institutions
- Aga Khan University (PK)
- Rochester General Hospital (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1001/jamainternmed.2025.5049
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00